Company intelligence / Profile preview

dabl

Dublin, Ireland

Ownership: Private
Development stage: Other

Overview

dabl specializes in advanced software systems and services for collecting, validating, and analyzing blood pressure data (ABPM, home, and office) in multi-site global clinical trials, particularly for cardiovascular endpoints in studies on hypertension, diabetes, obesity, and other areas. The company offers real-time data validation, protocol-specific configuration, logistics support, and statistical services to achieve high evaluable data rates and patient retention.

Industry: Contract Research Organization

Beyond the preview

Go deeper on dabl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dabl.

Explore the full profile